Catholic University of the Sacred Heart

A clinical trial presented at ERS Congress 2024 revealed that sulthiame, an epilepsy medication, effectively reduced obstructive sleep apnea symptoms by improving oxygen levels and decreasing breathing interruptions during sleep.

Analysis of recent idiopathic pulmonary fibrosis (IPF) trial failures emphasizes the importance of learning from setbacks to refine future clinical trial designs.